| Literature DB >> 35160962 |
Roxana Nicoleta Ionescu1, Alexandra Ripszky Totan2, Marina Meleșcanu Imre3, Ana Maria Cristina Țâncu3, Mihaela Pantea4, Mihai Butucescu5, Alexandru Titus Farcașiu6.
Abstract
The purpose of this study is to outline relevant elements regarding the biochemical interactions between prosthetic materials used for obtaining implant-supported restorations and the oral environment. Implant-supported prostheses have seen unprecedented development in recent years, benefiting from the emergence of both new prosthetic materials (with increased biocompatibility and very good mechanical behavior), and computerized manufacturing technologies, which offer predictability, accuracy, and reproducibility. On the other hand, the quality of conventional materials for obtaining implant-supported prostheses is acknowledged, as they have already proven their clinical performance. The properties of PMMA (poly (methyl methacrylate))-which is a representative interim material frequently used in prosthodontics-and of PEEK (polyether ether ketone)-a biomaterial which is placed on the border between interim and final prosthetic use-are highlighted in order to illustrate the complex way these materials interact with the oral environment. In regard to definitive prosthetic materials used for obtaining implant-supported prostheses, emphasis is placed on zirconia-based ceramics. Zirconia exhibits several distinctive advantages (excellent aesthetics, good mechanical behavior, biocompatibility), through which its clinical applicability has become increasingly wide. Zirconia's interaction with the oral environment (fibroblasts, osteoblasts, dental pulp cells, macrophages) is presented in a relevant synthesis, thus revealing its good biocompatibility.Entities:
Keywords: biochemical interactions; implant-supported restorations; prosthetic dental materials
Year: 2022 PMID: 35160962 PMCID: PMC8839238 DOI: 10.3390/ma15031016
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Methyl methacrylate polymerization reaction.
Figure 2PEEK (polyether ether ketone) molecular structure, (A) phenylene rings (aryl), (B) oxygen bridges (R-O-R), (C) carbonyl groups (R-CO-R).
Figure 3The yttria-stabilized zirconia structure.
Examples of in vitro and in vivo zirconia biocompatibility studies.
| Studied Cell Type and/or Tissue | Study Conclusions | Reference |
|---|---|---|
| Fibroblasts | Yttria-stabilized tetragonal zirconia polycrystals (3Y-TZPs) ceramic did not induce any mutagenic or cellular transforming effects. | [ |
| Osteoblasts | Zirconia ceramics did not alter cell ploidy or the cell growth rate. | [ |
| Macrophages | Zirconia ceramics particles induced macrophage apoptotic cell death, in vitro. | [ |
| Fibroblasts; | ZrO2/Al2O3 composite showed no cytotoxicity and no significant adverse effects in soft tissues. | [ |
| Osteoblasts | Zirconia samples insured good levels of biocompatibility. | [ |
| Osteoblasts | ZrO2, Al2O3, and PMMA (poly (methyl methacrylate)) particles triggered direct effects on osteoblasts. Cell responses depended on the particle type. ZrO2 effect on alkaline phosphatase activity was targeted to the matrix vesicles. | [ |
| Bone and muscle; | New zirconia implants illustrated good biocompatibility and mechanical properties. | [ |
|
Osteosarcoma-derived | Zirconia particles affected the viability of SaOs-2 and HGF, but did not induce proinflammatory reactions in THP-1. | [ |
| Human dental pulp stem cells; | Zirconia as a potential dental implant material, illustrated similar or, even, better initial cellular responses versus titanium. | [ |